High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India

Journal of Infection in Developing Countries

Volumn 3, Issue 6, 2009, Pages 467-469

  Kumar, Yashwant ^a   Sharma, Anshu ^a   Mani, Kavaratty Raju ^a  

^a Central Research Institute   (Turkey)

Author keywords

India; Nalidixic acid; Resistance; Salmonella Typhi

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; ESCHERICHIA; INDIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SALMONELLA TYPHI;

ESCHERICHIA; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI;

EID: 73249125167     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.419     Document Type: Article

References (17)

1. Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, Rao M, Naficy A, Clemens JD, Bhan MK. (1999) Typhoid fever in children aged less than 5 years. Lancet 354: 734-737.
2. Mermin JH, Townes JM, Gerber M, Dolan N, Mintz ED, Tauxe RV (1998) Typhoid fever in the United States, 1985-1994: Changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 158:633-638.
3. Wain J, Hoa NT, Chinh NT, Vinh H, Everett MJ, Diep TS, Day NPJ, Solomon T, White NJ, Piddock LJV, Parry CM. (1997) Quinolone-resistant Salmonella Typhi in Viet Nam: Molecular basis of resistance and clinical response to treatment. Clin Infect Dis 25: 1404-1410.
4. th 270 ed. Baltimore: Williams and Wilkins. 175-201.
5. Popoff MY, Le Minor L (1992) Antigenic formulas of the Salmonella serovars. 7th revision. WHO Collaborating Centre for Reference 264 Research on Salmonella. Paris: Institute Pasteur.
6. Wayne PA National Committee for Clinical Laboratory Standards (2000) National Committee for Clinical Laboratory Standards: Performance Standards for antimicrobial disc susceptibility tests, 7th ed. Approved standards M2-A6.
7. Wayne PA. Clinical and Laboratory Standards Institute (2006) Clinical and Laboratory Standards Institution: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved standard, CLSI document M7-A7.
8. Rodrigues C, Mehta A, Joshi VR (1999) Nalidixic acid-resistant Salmonella Typhi in Mumbai. Natl Med J India 12:88.
9. Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A (2005) Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella Typhi. BMC Infectious Diseases 5: 37.
10. Kapil A, Das B (2002) Nalidixic acid susceptibility to screen ciprofloxacin resistance in Salmonella Typhi. Indian J Med Res 115: 49-54.
11. Hakanen AJ, Lindgren M, Huovinen P, Jalava J, Siitonen A, Kotilainen P (2005) New Quinolone Resistance Phenomenon in Salmonella enterica: Nalidixic Acid-Susceptible Isolates with Reduced Fluoroquinolone Susceptibility. J Clin Micro 43(11): 5775-5778.
12. Cebrián L, Rodríguez JC, Escribano I, Royo G (2005) Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: Importance of efflux pump mechanisms. Chemotherapy 51: 40-43.
13. Piddock LJ, Jin YF, Webber MA, Everett MJ (2002) Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus. Antimicrob. Ag. Chemother. 46: 2276-2278.
14. Malorny B, Schroeter A, Guerra B, Helmuth R (2003) Incidence of quinolone resistance in strains of Salmonella isolated from poultry, cattle and pigs in Germany between 1998 and 2001.Vet Rec 153: 643-8.
15. Sang-Ho C, Woo JH, Lee1 JE, Park SJ, Choo EJ, Kwak YG, Kim MN, Choi, MS, Lee NY, Lee BK, Kim NJ, Jeong JY, Ryu J, Kim YS (2005) Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. Journal of Antimicrobial Chemotherapy 56: 1111-1114.
16. Hakanen AJ, Kotilainen P, Pitkänen S, Huikko S, Siitonen A, Huovinen P (2006) Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients. Journal of Antimicrobial Chemotherapy 57: 569-572.
17. Vasallo, FJ, Martin-Rabadan P, Alcala L, Garcia-Lechuz JM, Rodriguez-Creixems M, Bouza E (1998) Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin Infect Dis 26: 535-536.